Education
About Us
Working with TipRanks
Follow Us
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
| Dec 24 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ 0.00 |
| Operating Income | $ -479.00 |
| EBITDA | $ 0.00 |
| Net Income | $ -479.00 |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 1.35K |
| Total Assets | $ 551.00 |
| Total Debt | $ 662.00 |
| Net Debt | $ 661.00 |
| Total Liabilities | $ 796.00 |
| Stockholders' Equity | $ -244.00 |
| Cash Flow | |
| Free Cash Flow | $ -295.00 |
| Operating Cash Flow | $ -295.00 |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 173.62K |
Drugs Made In America Acquisition Corp. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.